Dernière mise à jour :
11/01/2017
Stabilité et compatibilité des médicaments
Bienvenue dans Stabilis.
Si vous désirez recevoir la newsletter trimestrielle, indiquez votre adresse email.

Pour toute question ou remarque, contactez : infostab@stabilis.org
Base de données  
Références bibliographies : 2125
Molécules : 749
Classes pharmacologiques : 40
Stabilités en solution : 4625
Stabilités en mélange : 990
Incompatibilités : 2776
Noms commerciaux : 1937
Nouveautés - Molécules  
Antibiotique Solution buvable Clindamycine hydrochloride 11/01/2017
Inhibiteur de la pompe à proton Solution buvable Esomeprazole magnesium trihydrate 11/01/2017
Divers Injectable Plerixafor 28/11/2016
Hypoglycémiant Solution buvable Glibenclamide 18/11/2016
Vasodilatateur Forme dermique Nitroglycérine 09/11/2016
Vasodilatateur Forme dermique Nifedipine 09/11/2016
Antihypertenseur Solution buvable Bosentan monohydrate 03/11/2016
Cytostatique Injectable Nivolumab 24/08/2016
Divers Injectable Tranexamic acid 24/08/2016
Divers Forme dermique 8-methoxypsoralen 04/08/2016
Antiépileptique Injectable Valproic acid 03/07/2016
Antiinflammatoire Injectable Betamethasone sodium phosphate 05/06/2016
Vitamine Injectable Cyanocobalamine 05/06/2016
Divers Injectable Thiocolchicoside 05/06/2016
Divers Injectable Ferric carboxymaltose 05/06/2016
Divers Solution buvable Levodopa/Carbidopa 22/05/2016
Antidépresseur Solution buvable Imipramine hydrochloride 22/05/2016
Anxiolytique Solution buvable Lorazepam 22/05/2016
Antibiotique Solution buvable Minocycline hydrochloride 22/05/2016
Antiinflammatoire Solution buvable Penicillamine-D 22/05/2016
Nouveautés - Références bibliographies  
Date de saisie
3913 Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. EJHP 03/12/2016
3895 Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients Ann Pharmacotherapy 06/09/2016
3896 Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period Pharmaceutical Technology in Hospital Pharmacy 06/09/2016
3897 Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. Pharmaceutical Technology in Hospital Pharmacy 06/09/2016
3898 Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients EJHP 06/09/2016
3892 Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions Can J Hosp Pharm 31/08/2016
3893 Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions Can J Hosp Pharm 31/08/2016
3891 Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C Can J Hosp Pharm 16/08/2016
3879 Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures. Int J Pharm Compound 03/08/2016
3880 Stability of Ampicillin in Normal Saline and Buffered Normal Saline. Int J Pharm Compound 03/08/2016
3881 Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. Int J Pharm Compound 03/08/2016
3885 Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method. Int J Pharm 03/08/2016
3886 Design and stability study of an oral solution of amlodipine besylate for pediatric patients. Eur J Pharm Sci 03/08/2016
3887 Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions. Perit Dial Int 03/08/2016
3888 Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study). Perit Dial Int 03/08/2016
3873 Incompatibility between irinotecan and fluorouracil injections Am J Health-Syst Pharm 27/07/2016
3874 Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes Ann Pharm Fr 27/07/2016
3875 Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus. EJHP 27/07/2016
3872 Stability of an Extemporaneously Compounded Oral Suspension of Bosentan Hosp Pharm 23/06/2016
3871 Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 07/06/2016
3868 Incompatibility of busulfan with 1 ml Luer-Lock syringes. J Oncol Pharm Practice 19/05/2016
3865 Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 17/05/2016
3866 Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. Int J Pharm Compound 17/05/2016
3863 Nivolumab (Opdivo®) - Summary of Products characteristics Bristol Myers Squibb 29/04/2016
3862 Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions. Hosp Pharm 22/04/2016
3860 Stability of trimethoprim in newly formulated liquid dosage form. J Pharm Pract and Res 18/04/2016
3861 Evaluation of stability of melatonin in extemporaneously compounded oral suspensions. J Pharm Pract and Res 18/04/2016
3859 Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems. RRJHCP 16/04/2016
3856 Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Int J Pharm Compound 08/04/2016
3857 Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Int J Pharm Compound 08/04/2016

Temps de calcul serveur : 78 millisecondes